Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of VZV and HSV Infections in Children, Phase I (VALID-I)

NCT01689285 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01689285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01689285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of VZV and HSV Infections in Children, Phase I (VALID-I)
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2013
Completion date
July 31, 2015
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex virus infection, varicella zoster virus infection